Myeloproliferative Neoplasms

The New England Journal of Medicine published a comprehensive review article on myeloproliferative neoplasms (MPNs), covering the current understanding of pathogenesis, diagnosis, and management across the disease spectrum. The 15-page review consolidates the evolving landscape of MPNs, including polycythaemia vera, essential thrombocythaemia, and primary myelofibrosis. As an authoritative state-of-the-art reference in NEJM, the article is expected to inform clinical practice but does not report novel trial data or a new therapeutic breakthrough.